Brüderkrankenhaus St. Josef Paderborn

Hospital


Location: Paderborn, Germany (DE) DE

ISNI: 0000000405574388

ROR: https://ror.org/02mwnke68

Show on Map:

Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study (2023) Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project (2023) Braulke F, Para S, Alt-Epping B, Tewes M, Bäumer M, Haberland B, Mayer-Steinacker R, et al. Journal article Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI-Results from OCUM trial (2022) Stelzner S, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial (2020) Fietkau R, Hecht M, Hofner B, Lubgan D, Iro H, Gefeller O, Rödel C, et al. Journal article Radiotherapy with paclitaxel/cisplatin vs. fluorouracil/cisplatin for head and neck cancer (2019) Fietkau R, Hecht M, Hofner B, Iro H, Gefeller O, Roedel C, Hautmann M, et al. Conference contribution MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial (2019) Kreis ME, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article